Current Research Studies

A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Axa and Rux for GVHD

  • Condition(s): Unknown Sites
  • Phase: II
  • Clinicaltrials.gov ID: NCT06388564

What is the goal of the study?

This is a drug study that will determine the preliminary efficacy of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with cGVHD.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: